V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20204101 | 20127123 | 1.61 | 64.8 | null | 2019-12-13 | 2019-12-30 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CAPECITABINE + CARBOPLATIN | 101272329 |
| 20204109 | 20127124 | 1.68 | 69 | Palliative (P) | null | 2018-05-15 | GEMCITABINE + NAB PACLITAXEL | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100726984 |
| 20204111 | 20127125 | 1.74 | 73.2 | Palliative (P) | 2016-02-27 | 2016-03-20 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 101052060 |
| 20204120 | 20127126 | 1.79 | 72.7 | Adjuvant (A) | null | 2020-01-25 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100336898 |
| 20204128 | 20127127 | 1.8 | 48.2 | Palliative (P) | null | 2018-07-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101060455 |
| 20204129 | 20127128 | 1.77 | 86.8 | Palliative (P) | null | 2017-08-10 | HCX (Cape + Cisp + Tras) - Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100691835 |
| 20204139 | 20127129 | 0 | 80.8 | Palliative (P) | 2018-06-08 | 2018-06-14 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101578700 |
| 20204140 | 20127130 | 1.88 | 75.7 | Curative (C) | null | 2020-01-11 | GEMCITABINE + NAB PACLITAXEL | null | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100629531 |
| 20204147 | 20127131 | 1.7 | 72 | Palliative (P) | 2018-06-10 | 2018-06-11 | GEMCITABINE + NAB PACLITAXEL | N | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101560649 |
| 20204152 | 20127132 | 1.8 | 53.5 | null | 2017-06-05 | 2017-06-12 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101125446 |
| 20204153 | 20127133 | 1.74 | 89.5 | null | 2018-04-16 | 2018-04-17 | HCX (Cape + Cisp + Tras) - Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100004936 |
| 20204166 | 20127134 | 1.59 | 59.1 | null | 2017-03-02 | 2017-03-06 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101074258 |
| 20204169 | 20127135 | 1.76 | 73.6 | Palliative (P) | 2019-05-30 | 2019-06-04 | Cape+Cisplatin+Trastuzumab Load | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101110720 |
| 20204181 | 20127136 | 1.77 | 51 | Palliative (P) | 2018-08-21 | 2018-08-21 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101864878 |
| 20204183 | 20127137 | 1.7 | 99.4 | null | 2017-07-10 | 2017-07-28 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101750137 |
| 20204188 | 20127138 | 1.7 | 59.7 | Palliative (P) | 2020-09-01 | 2020-09-23 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | CAPECITABINE + CARBOPLATIN | 101819868 |
| 20204189 | 20127139 | 1.82 | 87 | Palliative (P) | 2019-05-19 | 2019-06-27 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 101132955 |
| 20204192 | 20127140 | 1.72 | 67.8 | Palliative (P) | 2018-03-18 | 2018-08-31 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101219380 |
| 20204199 | 20127141 | 1.72 | 56.5 | Adjuvant (A) | null | 2020-12-17 | GEMCITABINE + NAB PACLITAXEL | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100431387 |
| 20204203 | 20127142 | 1.64 | null | Palliative (P) | 2016-04-13 | 2016-04-17 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101226503 |
| 20204208 | 20127143 | 1.6 | 64.15 | 03 | 2017-04-30 | 2017-04-30 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100114677 |
| 20204210 | 20127144 | 1.8 | 90 | 02 | 2017-12-19 | 2018-01-06 | GEMCITABINE + NAB PACLITAXEL | N | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100452771 |
| 20204211 | 20127145 | 1.6 | 66.9 | Palliative (P) | 2019-10-15 | 2019-10-17 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100856654 |
| 20204213 | 20127146 | 1.73 | 75.7 | Palliative (P) | 2017-12-15 | 2017-12-15 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101514647 |
| 20204224 | 20127147 | 1.81 | null | Palliative (P) | 2017-04-04 | 2017-05-28 | CAPECITABINE + CISPLATIN + Trastuzumab | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100930910 |
| 20204231 | 20127148 | 1.72 | 88.8 | Palliative (P) | 2020-05-05 | 2020-05-12 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100176679 |
| 20204232 | 20127149 | 1.7 | 78 | Adjuvant (A) | 2018-02-23 | 2018-03-18 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101549677 |
| 20204233 | 20127150 | 1.68 | 80.3 | null | 2019-04-07 | 2019-04-07 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 100070905 |
| 20204234 | 20127151 | 1.65 | 78.2 | Palliative (P) | 2019-05-10 | 2019-05-24 | GEMCITABINE + NAB PACLITAXEL | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100801616 |
| 20204250 | 20127152 | 1.57 | 113.5 | Neo-adjuvant (N) | 2016-11-12 | 2016-11-12 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 101817553 |
| 20204253 | 20127153 | 1.97 | 62.2 | Palliative (P) | 2016-11-24 | 2016-12-08 | Cape+Cisplatin+Trastuzumab Main | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101757457 |
| 20204256 | 20127154 | 1.87 | 82.6 | Adjuvant (A) | 2018-03-03 | 2018-03-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100880857 |
| 20204258 | 20127155 | 1.64 | 87.5 | null | 2016-12-24 | 2016-12-24 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 100947924 |
| 20204259 | 20127156 | 1.6 | 56 | Palliative (P) | 2018-05-26 | 2018-05-29 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100721326 |
| 20204261 | 20127157 | 1.85 | 78.65 | null | 2015-10-15 | 2016-03-27 | Cape+Cisplatin+Trastuzumab Main | null | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101579087 |
| 20204264 | 20127158 | 1.7 | 60.9 | Palliative (P) | 2021-04-06 | 2021-04-07 | CAPECITABINE + CARBOPLATIN | 02 | N | CAPECITABINE + CARBOPLATIN | 100198633 |
| 20204266 | 20127159 | 1.61 | 68.1 | Neo-adjuvant (N) | 2018-01-24 | 2018-02-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101778415 |
| 20204268 | 20127160 | 1.68 | 58.5 | null | 2017-11-20 | 2018-04-28 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100448469 |
| 20204277 | 20127161 | 1.74 | 69.5 | Palliative (P) | 2017-06-02 | 2017-06-22 | Capecitabine (21days) + Carboplatin | 02 | N | CAPECITABINE + CARBOPLATIN | 100796454 |
| 20204279 | 20127162 | 1.77 | 62.9 | null | 2019-04-08 | 2019-07-09 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100004778 |
| 20204291 | 20127163 | 1.6 | 76.7 | Palliative (P) | null | 2018-10-23 | GEMCITABINE + PACLITAXEL ALBUMIN (ABRAXANE) | 02 | N | GEMCITABINE + NAB-PACLITAXEL | 100470100 |
| 20204300 | 20127164 | 1.93 | 58 | Palliative (P) | 2017-02-24 | 2017-03-01 | Cape+Cisplatin+Trastuzumab Main | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101159125 |
| 20204302 | 20127165 | 1.84 | 112 | Palliative (P) | 2017-05-17 | 2017-06-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100252047 |
| 20204303 | 20127166 | 1.73 | 80.5 | Curative (C) | 2020-11-26 | 2020-11-26 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100326038 |
| 20204305 | 20127167 | 1.59 | 40 | null | 2017-09-01 | 2018-04-01 | GEMCITABINE + NAB PACLITAXEL | 02 | null | GEMCITABINE + NAB-PACLITAXEL | 101762077 |
| 20204309 | 20127168 | 1.73 | 105.7 | Palliative (P) | null | 2019-01-11 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101106497 |
| 20204313 | 20127169 | 1.65 | 80.6 | null | 2016-12-31 | 2017-06-27 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100062480 |
| 20204314 | 20127170 | 1.95 | 69.8 | null | 2016-10-06 | 2016-10-26 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | null | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 101158080 |
| 20204315 | 20127171 | 1.72 | 57.5 | Palliative (P) | 2018-06-19 | 2018-06-20 | CAPECITABINE + CISPLATIN + Trastuzumab | 02 | N | CAPECITABINE + CISPLATIN + TRASTUZUMAB | 100455519 |
| 20204320 | 20127172 | 1.78 | 73.2 | null | 2016-12-21 | 2017-03-17 | Capecitabine (21days) + Carboplatin | 02 | null | CAPECITABINE + CARBOPLATIN | 101709670 |